secwatch.observer — SEC 8-K summary
======================================

Issuer:     DarioHealth Corp. (DRIO)
CIK:        0001533998
Form:       8-K
Filed at:   2023-05-05T23:59:59+00:00
Accession:  0001104659-23-056519
Event type: other_material
Sentiment:  positive
Materiality: 0.80
Item codes: 1.01, 1.02, 2.03, 3.02, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

DarioHealth completes $15.4M preferred stock placement and $30M credit facility refinancing
--------------------------------------------------------------------------------

- Raised ~$15.4M via convertible preferred stock (Series B, B-1, B-2, B-3) at $1,000/share; conversion prices $3.334-$3.392.
- New $30M secured credit facility from Avenue Venture Funds; $30M initial tranche closed; up to $10M additional available after July 2023.
- Proforma cash $60M after transactions; expects cash runway through late 2025; saves ~$6M annually in amortization payments.
- Approximately half of preferred shares bought by insiders, including management and board; Avenue receives warrant for 584,882 shares at $3.334.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1533998/000110465923056519/0001104659-23-056519-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1533998/000110465923056519/tm2314673d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-056519

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer